• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.49% Nasdaq Up0.68%

    Sarepta Therapeutics, Inc. (SRPT)

    -NMS
    13.41 Down 0.40(2.86%) 3:39PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (111,985) (121,287) (2,318)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,277  1,525  1,300  
    Adjustments To Net Income33,744  95,373  (29,594)
    Changes In Accounts Receivables2,801  (3,587)(1,063)
    Changes In Liabilities9,468  (1,718)7,996  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities -   -   -  
    Total Cash Flow From Operating Activities (64,695) (29,694) (23,679)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(2,370)(108)(1,178)
    Investments(7,897) -   -  
    Other Cash flows from Investing Activities(1,405)(1,037)(1,127)
    Total Cash Flows From Investing Activities (11,672) (1,145) (2,305)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock145,986  178,681  32,380  
    Net Borrowings(89)(85)(81)
    Other Cash Flows from Financing Activities(226) -   -  
    Total Cash Flows From Financing Activities 145,671   178,596   32,299  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 69,304   147,757   6,315  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.